| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

Pediatric Research Institute, Cardinal Glennon Children's Hospital, and St. Louis University (N.C.P., A.J.K.); and the Division of Dermatology, Washington University School of Medicine (J.J.J., L.S.E.), and the Division of Dermatology (C.F., H.G. W.) and the Department of Pathology (S.L.T.), Jewish Hospital at Washington University Medical Center St. Louis, Missouri 63110
Shriners Hospitals for Crippled Children, St. Louis Unit St. Louis, Missouri63131 (S.L.T.)
Address all correspondence and requests for reprints to: Dr. N. C. Partridge, Pediatric Research Institute, 3662 Park Avenue, St. Louis, Missouri 63110.
Abstract
Collagenases that specifically cleave native collagen at neutral pH have been implicated in the maintenance and turnover of connective tissue. In bone, the origin of neutral collagenase has remained equivocal, although recent studies have indicated that it is synthesized by the osteoblast. In the present work, regulation of secretion of neutral collagenase and a collagenase inhibitory activity was investigated using the osteoblastic tumor cell line UMR 106-01 and a variety of bone-resorbing agents. Under basal conditions, UMR 106-01 cells produced very low levels of collagenase but substantial amounts of the inhibitory activity. Exposure to PTH and, to a lesser extent, 1,25-dihydroxyvitamin D3, prostaglandin E2, retinoic acid, and epidermal growth factor stimulated the release of collagenase, an effect not seen with interleukin-1 or heparin. The stimulation of collagenase by PTH was dose dependent, with a half-maximal response occurring at 10-8 M. Inclusion of isobutylmethylxanthine decreased the concentration of PTH required to produce half-maximal stimulation to 2 x 10-10 M, indicating action via cAMP. With respect to the inhibitory activity, PTH and epidermal growth factor were the only agents, among those tested, able to enhance its production. Both hormones caused a 50–100% increase over control levels 72 h after hormone administration. There were notable differences in the time courses of production of collagenase and the inhibitor. After treatment with PTH, the enzyme reached maximal concentrations between 12–48 h, but declined to undetectable levels by 96 h. In contrast, the inhibitory activity was secreted in a linear fashion, with the highest concentrations achieved around 72–96 h. These results suggest a complex pattern of regulation of collagenase and inhibitor secretion by the osteoblastic cell, with the steady accumulation of inhibitor perhaps being responsible for the ultimate curtailment of enzyme activity. (Endocrinology 120: 1956–1962,1987)
Footnotes
* This work was supported by USPHS Grants HD-05291, AM-32788, and AM-35805 and the Shriners Hospitals for Crippled Children (Project 15959).
C. J. Martin Fellow of the National Health and Medical Research Council of Australia.
Received May 16, 1986.
This article has been cited by other articles:
![]() |
R. J. Midura, X. Su, J. A. Morcuende, M. Tammi, and R. Tammi Parathyroid Hormone Rapidly Stimulates Hyaluronan Synthesis by Periosteal Osteoblasts in the Tibial Diaphysis of the Growing Rat J. Biol. Chem., December 19, 2003; 278(51): 51462 - 51468. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Onodera, J. Nishihira, K. Iwabuchi, Y. Koyama, K. Yoshida, S. Tanaka, and A. Minami Macrophage Migration Inhibitory Factor Up-regulates Matrix Metalloproteinase-9 and -13 in Rat Osteoblasts. RELEVANCE TO INTRACELLULAR SIGNALING PATHWAYS J. Biol. Chem., March 1, 2002; 277(10): 7865 - 7874. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Y. Barmina, H. W. Walling, G. J. Fiacco, J. M. P. Freije, C. Lopez-Otin, J. J. Jeffrey, and N. C. Partridge Collagenase-3 Binds to a Specific Receptor and Requires the Low Density Lipoprotein Receptor-related Protein for Internalization J. Biol. Chem., October 15, 1999; 274(42): 30087 - 30093. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Pereira, V. Jorgetti, and E. Canalis Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E496 - E504. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gazzerro, S. Rydziel, and E. Canalis Skeletal Bone Morphogenetic Proteins Suppress the Expression of Collagenase-3 by Rat Osteoblasts Endocrinology, February 1, 1999; 140(2): 562 - 567. [Abstract] [Full Text] |
||||
![]() |
A. M. Delany and E. Canalis Dual Regulation of Stromelysin-3 by Fibroblast Growth Factor-2 in Murine Osteoblasts J. Biol. Chem., June 26, 1998; 273(26): 16595 - 16600. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Selvamurugan, W.-Y. Chou, A. T. Pearman, M. R. Pulumati, and N. C. Partridge Parathyroid Hormone Regulates the Rat Collagenase-3 Promoter in Osteoblastic Cells through the Cooperative Interaction of the Activator Protein-1 Site and the runt Domain Binding Sequence J. Biol. Chem., April 24, 1998; 273(17): 10647 - 10657. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kusano, C. Miyaura, M. Inada, T. Tamura, A. Ito, H. Nagase, K. Kamoi, and T. Suda Regulation of Matrix Metalloproteinases (MMP-2, -3, -9, and -13) by Interleukin-1 and Interleukin-6 in Mouse Calvaria: Association of MMP Induction with Bone Resorption Endocrinology, March 1, 1998; 139(3): 1338 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Holliday, H. G. Welgus, C. J. Fliszar, G. M. Veith, J. J. Jeffrey, and S. L. Gluck Initiation of Osteoclast Bone Resorption by Interstitial Collagenase J. Biol. Chem., August 29, 1997; 272(35): 22053 - 22058. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Franchimont, S. Rydziel, A. M. Delany, and E. Canalis Interleukin-6 and Its Soluble Receptor Cause a Marked Induction of Collagenase 3 Expression in Rat Osteoblast Cultures J. Biol. Chem., May 2, 1997; 272(18): 12144 - 12150. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Varghese and E. Canalis Regulation of Collagenase-3 by Bone Morphogenetic Protein-2 in Bone Cell Cultures Endocrinology, March 1, 1997; 138(3): 1035 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Delaisse, Y Eeckhout, L Neff, C Francois-Gillet, P Henriet, Y Su, G Vaes, and R Baron (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment J. Cell Sci., January 12, 1993; 106(4): 1071 - 1082. [Abstract] [PDF] |
||||
![]() |
H. Birkedal-Hansen, W.G.I. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J.A. Engler Matrix Metalloproteinases: A Review Critical Reviews in Oral Biology & Medicine, January 1, 1993; 4(2): 197 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Meikle, S. Bord, R. M. Hembry, J. Compston, P. I. Croucher, and J. J. Reynolds Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines J. Cell Sci., December 1, 1992; 103(4): 1093 - 1099. [Abstract] [PDF] |
||||
![]() |
S. K. Winchester, N. Selvamurugan, R. C. D'Alonzo, and N. C. Partridge Developmental Regulation of Collagenase-3 mRNA in Normal, Differentiating Osteoblasts through the Activator Protein-1 and the runt Domain Binding Sites J. Biol. Chem., July 21, 2000; 275(30): 23310 - 23318. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |